ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
92,526.49
-2.66%
S&P 500
5,918.25
0.00%
Dow Jones
42,635.20
0.00%
US Dollar vs Yen
158.1285
-0.06%
Brent Oil
76.925
1.23%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ

  6. Recursion Pharmaceuticals Inc (RXRX) 銘柄情報

Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals Inc (RXRX)

NASDAQ
7.26
0.00
(0.00%)
終了 1月10日 6:00AM
15分遅延
0.00
0.00
(0.00%)
取引時間後: -
15分遅延

個人投資家向けのプロ仕様のツール。

プレミアム

主要統計と詳細

通貨
7.26
買値
7.25
売値
7.26
出来高
-
0.00 日の範囲 0.00
5.60 52 週間の範囲 15.74
時価総額
2.081B
前日終値
7.26
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
11,851,903
発行済株式数
286,640,833
配当利回り
-
PER
-6.34
1 株当たり利益 (EPS)
-1.14
歳入
44.58M
純利益
-328.07M

Recursion Pharmaceuticals Inc について

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery... Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. 詳細を表示

セクター
Biological Pds,ex Diagnstics
業界
Biological Pds,ex Diagnstics
ウェブサイト
www.recursion.com
本社
Wilmington, Delaware, USA
設立
-
Recursion Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker RXRX. The last closing price for Recursion Pharmaceuticals was US$7.26. Over the last year, Recursion Pharmaceuticals shares have traded in a share price range of US$ 5.60 to US$ 15.74.

Recursion Pharmaceuticals currently has 286,640,833 shares in issue. The market capitalisation of Recursion Pharmaceuticals is US$2.08 billion. Recursion Pharmaceuticals has a price to earnings ratio (PE ratio) of -6.34.

Recursion Pharmaceuticals (RXRX) のオプションフロー概要

オプションフロー全体を表示

全体の流れ

ブルリッシュ

ネットプレミアム

34k

Calls / Puts

100.00%

買い / 売り

0.00%

OTM / ITM

100.00%

Sweeps比率

0.00%

RXRX 最新ニュース

その他のニュース

Form 144 - Report of proposed sale of securities

2025年1月9日
Edgar (US Regulatory)

Recursion Announces Two Key Investigational Oncology Drugs Advancing to Clinical Trials, Targeting High Unmet Needs in Hematologic Malignancies, Small-Cell Lung Cancer, & More

REC-3565 is a potential best-in-class MALT1 inhibitor for multiple hematology indications, designed to reduce the risk of hyperbilirubinemia, a common side effect of other MALT1 inhibitors...

2025年1月7日
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

2025年1月7日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2025年1月7日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2025年1月7日
Edgar (US Regulatory)

Recursion to Present at 43rd Annual JP Morgan Healthcare Conference

Salt Lake City, UT, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, today announces that...

2025年1月6日
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

2024年12月27日
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月21日
Edgar (US Regulatory)

Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules

Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“Recursion”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize...

2024年12月21日
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

2024年12月19日
Edgar (US Regulatory)
期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.375.370101596526.898.666.71172073107.58502142CS
4-0.26-3.457446808517.528.665.93160651567.0784955CS
120.162.253521126767.19.555.6118519036.98822753CS
26-0.14-1.891891891897.49.555.680896606.98697103CS
52-5.2-41.733547351512.4615.745.670760378.36517993CS
156-8.3-53.341902313615.5616.7454.5439437268.78471563CS
260-22.74-75.83042.814.5433389649.49690591CS

RXRX - Frequently Asked Questions (FAQ)

What is the current Recursion Pharmaceuticals share price?
The current share price of Recursion Pharmaceuticals is US$ 7.26
How many Recursion Pharmaceuticals shares are in issue?
Recursion Pharmaceuticals has 286,640,833 shares in issue
What is the market cap of Recursion Pharmaceuticals?
The market capitalisation of Recursion Pharmaceuticals is USD 2.08B
What is the 1 year trading range for Recursion Pharmaceuticals share price?
Recursion Pharmaceuticals has traded in the range of US$ 5.60 to US$ 15.74 during the past year
What is the PE ratio of Recursion Pharmaceuticals?
The price to earnings ratio of Recursion Pharmaceuticals is -6.34
What is the cash to sales ratio of Recursion Pharmaceuticals?
The cash to sales ratio of Recursion Pharmaceuticals is 46.69
What is the reporting currency for Recursion Pharmaceuticals?
Recursion Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Recursion Pharmaceuticals?
The latest annual turnover of Recursion Pharmaceuticals is USD 44.58M
What is the latest annual profit for Recursion Pharmaceuticals?
The latest annual profit of Recursion Pharmaceuticals is USD -328.07M
What is the registered address of Recursion Pharmaceuticals?
The registered address for Recursion Pharmaceuticals is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Recursion Pharmaceuticals website address?
The website address for Recursion Pharmaceuticals is www.recursion.com
Which industry sector does Recursion Pharmaceuticals operate in?
Recursion Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0

RXRX Discussion

投稿を表示

最近閲覧した銘柄

NASDAQ
RXRX
Recursion Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2025 ADVFN PLC - 全著作権所有